Shopping Cart (0)
My Account

 Shopping Cart
Conferences | Training Courses | Market Reports | Managed Events | Past Conferences | Update Me
SELECTBIO Conferences Antibodies in Drug Discovery
Conferences  \  Advances in Drug Discovery  \  Antibodies in Drug Discovery  \  Agenda  \  Suzanne Cohen
RegisterLogin

Suzanne Cohen's Biography


Suzanne Cohen, , MedImmune

Suzanne joined MedImmune in 2001 after gaining a doctorate in Immunology at the University of Oxford, UK. She has over 15 years experience in preclinical and early clinical development of therapeutic antibodies and currently leads a team focused on lung disease research in the department of Respiratory, Inflammation and Autoimmunity (RIA) in Cambridge, UK.

Suzanne Cohen Image

Monoclonal Antibody Therapy for the Management of Severe Asthma

Monday, 6 March 2017 at 10:00

Add to Calendar ▼2017-03-06 10:00:002017-03-06 11:00:00Europe/LondonMonoclonal Antibody Therapy for the Management of Severe AsthmaSELECTBIOenquiries@selectbiosciences.com

Severe asthma involves a number of variants with different underlying pathologies. Genome Wide Association Studies have consistently implicated IL-33 and its receptor ST2 in asthma. IL-33 itself has intriguing biochemistry that has implications for antibody discovery.

Add to Calendar ▼2017-03-06 00:00:002017-03-07 00:00:00Europe/LondonAntibodies in Drug DiscoverySELECTBIOenquiries@selectbiosciences.com


Corporate Sponsors